Among the 14 genes, seven genes, i.e., KRT19, EMP1, CXCR4, CD44, PTEN, PARP2, and PLCB4, were required to have high expression levels in the original tumor cells, whereas others should have low expression levels. This evidence concerns the gene PARP2 and neoplasm.